Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reality isn’t “news soon” - that’s hoping. Reality is radio silence.
Tough to tell. There has been no correlation of LCE/Elite as LCI’s largest Adderall drug opportunity is not Elite’s.
Month to go until next conference call. I’d expect release after close on 15th with call on 16th.
Good news? The only news I heard is that the can got kicked down the road for another 2 years before any potential translation to new revenue growth. That news?
Or is it the news that Adderall ER is basically non-existent for Elite when they have been playing in a $1B market for over a year now?
Agree. To me this is a signal if we can barely penetrate this large of a market, we have major issues with partnerships and execution. We’ve had issues with partnerships for many years - Dr Reddy, Epic resurrected 2.0, Sungen, etc.
Completely agree 100%. ER is basically non-existent for the size of market it is. Deeply disappointing is a vast understatement.
Elite will get $0 benefit.
That’s what the CEO said about SequestOx and the FDA. Lots of fumbles since then.
I’m guessing you’re on the ask…
WeeZuhl and I discussed this months ago. I provided some examples based on financial releases. I’ll refrain from saying more.
Did someone forget to flip the ignition switch?
LCI continues to get hammered as well. Disappointment with Adderall ER partnership for sure hitting Elite.
For each LPC agreement the bottom has not only been tested, but destroyed basically nullifying current LPC paving way for another with a lower floor.
Look at all this volume. It must be something positive. Look at all the buyers. Lol
Will break under 4 cents today. Silence isn’t golden when it extends year after year. Investors hate uncertainty more than bad news and management at Elite provide little clarity into the uncertainty. Until then stock will continue to go south. Trust and credibility haven’t been able to be reestablished over many years.
New Jersey is a haven for pharmas. Dime a dozen out there.
Not according to FINDA. Just zero new interest & long time holders bailing.
More like Nasrat effect. Just more of what we’ve seen for past 8 years.
Soon = 18-24 months with lots of downward selling pressure until then. This won’t hit a nickel again for a while.
And a whole lot less as well. Why would it be worth a few billion for a handful of breadcrumbs barely being profitable? This goes against any sort of realistic valuation.
Except it doesn’t fit in Elite’s portfolio or capabilities. How many times does Nasrat have to answer this?
Just like the Codeine he has been trying to sell off for several years.
Must have been a massive hedge fund. Oh wait, only $10K exchanged hands today. Plus, it was down yet again. At least some things are consistent.
How long is that IP good for? Time is running out…
Rise of Eite won’t happen until there is worthy news. Loxapine just doesn’t quite cut the mustard with a billion shares outstanding.
May want to check the Orange Book.
Oh Captain, my Captain! Why dost ye only sail in rough seas? Why do we pitch good bounty overboard, destroy partnerships yet befriend the foe? Oh Captain, my Captain why sell our loot for pennies? For actions ring loud in my ears that we never had a Captain, but rather a pitiful pirate.
…and has nothing to do with Elite.
Well, it did, but there has been lots of selling the past few months. Don’t blame them. There’s only so much complacency one can take.
Total BS. Retail has tens of millions
Couple years back it hit ~3.4 cents…
Or maybe they are bailing because the stock has provided no ROI over the last 8 years.
I think the CEO said years ago that the stock won’t go to 3 cents. Actions always speak louder than words and where there is little action the market will judge accordingly.
Let me guess, another round of huge buyers swooped on today?
And looking at a chart will dictate otherwise. Same old, same old.
Funny how the red days are much more frequent and bigger in magnitude than the occasional green one.
ANDAs aren’t even submitted yet. No need on bioequivalency studies yet + add on 5-6 months after the study results to file + 10 months to review, assuming no CRL and a timely review.
We are eating the dust of slugs, snails and Mikah.
Pure garbage
IB - Bit confused at message. SequestOx was never approved and don’t think it ever will be. Nasrat sold off opioids and could never get movement on Codeine, which will be sold off for pennies on the dollar once again.